Dignitana Publishes May Newsletter
Lund, Sweden – 4 May 2018 – Dignitana AB, world leader in clinically superior scalp cooling technology, today publishes the May 2018 edition of the company newsletter. This edition features updates on company growth in Europe, product availability in the U.S., the Annual General Meeting, and U.S. insurance coverage.
The newsletter is attached here and posted at http://www.dignitana.se/newsletter/. The Dignitana IN BRIEF newsletter is published monthly for Dignitana shareholders and posts the first week of each month.
00 1 773 387 8504
About Dignitana AB (publ)
Dignitana is a Swedish public company based in Lund and manufacturer of the medical cooling device DigniCap®. Dignitana AB is listed on Nasdaq First North Stockholm and has appointed Erik Penser Bank as Certified Adviser. Headquartered in Dallas Texas, Dignitana, Inc. is the U.S. subsidiary of Dignitana AB. DigniCap®is a patented scalp cooling system that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and acceptable patient comfort.